Este sitio usa cookies, propias y de terceros.
Si se continúa con nosotros entendemos que se acepta el uso de cookies.

Congreso AHA 2012

Tema en 'Docencia y entrenamiento' comenzado por Belladonna, 1 Nov 2012.

Estado del tema:
No está abierto para más respuestas.
  1. Belladonna

    Belladonna Super Moderator Miembro del Equipo

    Etiquetas:
  2. Belladonna

    Belladonna Super Moderator Miembro del Equipo

    Respuesta: Congreso AHA 2012

    Late-Breaking Clinical Trials, AHA 2012
    Resultados de los Late-Breaking Clinical Trials.


    Domingo, 4 noviembre 2012 / Sunday, Nov. 4, 2012

    Aspirin for The Prevention of Recurrent Venous Thromboembolism After a First Unprovoked Event: Results of the ASPIRE Randomized Controlled Trial.
    http://blogrec.elsevier.es/?p=560&lang=esA Randomized Trial of Bedside Platelet Function Monitoring to Adjust Antiplatelet Therapy Versus Standard of Care in Patients Undergoing Drug Eluting Stent Implantation: The ARCTIC Study.
    http://blogrec.elsevier.es/?p=584&lang=es
    First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial - The TRILOGY ACS Platelet Function Sub-study.
    http://blogrec.elsevier.es/?p=577&lang=es
    Results of the Trial to Assess Chelation Therapy.
    http://blogrec.elsevier.es/?p=673&lang=es
    Main Results of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.
    http://blogrec.elsevier.es/?p=572&lang=es
    Prospective Evaluation of Outcomes With Stress Perfusion Imaging Versus Stress Wall Motion Imaging During Dobutamine or Exercise Echocardiography.
    http://blogrec.elsevier.es/?p=630&lang=es
    Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery.
    http://blogrec.elsevier.es/?p=594&lang=es
    Quality of Life Outcomes in the Trial to Assess Chelation Therapy (TACT).
    http://blogrec.elsevier.es/?p=677&lang=es
    Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease: Results from the FREEDOM Trial.
    http://blogrec.elsevier.es/?p=621&lang=es


    Lunes, 5 noviembre 2012 / Monday, Nov. 5, 2012


    Omega-3 fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: Results of a double-blind randomized clinical trial (FORWARD) (NCT00597220).
    http://blogrec.elsevier.es/?p=662&lang=esFish Oil for the Prevention of Post-Operative Atrial Fibrillation - The Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) Trial.
    http://blogrec.elsevier.es/?p=638&lang=es
    A Randomized Trial of a Multivitamin in the Prevention of Cardiovascular Disease in Men: The Physicians’ Health Study II.
    http://blogrec.elsevier.es/?p=648&lang=es
    Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE).
    http://blogrec.elsevier.es/?p=712&lang=es
    Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD): Interim Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.
    http://blogrec.elsevier.es/?p=681&lang=es
    Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects (GAUSS): Interim Results from a Randomized, Double-blind, Placebo-controlled Study.
    http://blogrec.elsevier.es/?p=667&lang=es
    Effects of 12 Weeks of Treatment with RN316 (PF-04950615), a Humanized IgG2Δa Monoclonal Antibody Binding Proprotein Convertase Subtilisin Kexin Type 9, in Hypercholesterolemic Subjects on High and Maximal Dose Statins.
    http://blogrec.elsevier.es/?p=747&lang=es
    Effects of the Cholesteryl Ester Transfer Protein Inhibitor Dalcetrapib in Patients with Recent Acute Coronary Syndrome.
    http://blogrec.elsevier.es/?p=642&lang=es

    Martes, 6 noviembre 2012 / Tuesday, Nov. 6, 2012


    Results of the Swiss Multicenter Intracoronary Stem Cells Study in Acute Myocardial Infarction (Swiss Ami) Trial.
    http://blogrec.elsevier.es/?p=791&lang=esThe Effect of Timing of Stem Cell Delivery Following Acute Myocardial Infarction: The NHLBI and CCTRN TIME Trial.
    http://blogrec.elsevier.es/?p=802&lang=es
    Randomized Comparison of Allogeneic vs Autologous Mesenchymal Stem Cells in Patients with Ischemic Cardiomyopathy.
    http://blogrec.elsevier.es/?p=692&lang=es
    Effect of Cardiac Stem Cells in Patients with Ischemic Cardiomyopathy: Interim Results of the SCIPIO Trial Up to 2 Years After Therapy.
    http://blogrec.elsevier.es/?p=764&lang=es
    MADIT Randomized Trial to Reduce Inappropriate Therapy (MADIT-RIT).
    http://blogrec.elsevier.es/?p=760&lang=es
    Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block (BLOCK HF Study).
    http://blogrec.elsevier.es/?p=779&lang=es
    Pilot Trial of Two Levels of Hypothermia in Comatose Survivors from Out-of-Hospital Cardiac Arrest.
    http://blogrec.elsevier.es/?p=752&lang=es
    The RELAXin in Acute Heart Failure (RELAX-AHF-1) Trial.
    http://blogrec.elsevier.es/?p=730&lang=es
    Cardiorenal Rescue Study in Acute Decompensated Heart Failure: Results of CARRESS-HF, for the Heart Failure Clinical Research Network.
    http://blogrec.elsevier.es/?p=726&lang=es
     
Estado del tema:
No está abierto para más respuestas.

Comparte esta página

Cargando...